MDS Pharma Services, Caprion Pharmaceuticals, Gentris, and Massachusetts General Hospital's department of radiology have teamed up to form a new Biomarker Alliance that offers clients proteomic, genomic, bioanalytic, and imaging technologies for developing biomarkers, the groups said last week.

Fred Pritchard, vice president of drug development programs at MDS Pharma Services, said that the idea behind the alliance is to enable clients to approach its members and discuss what might be the best one or two tools or techniques to apply to a particular question.